{
  "retracted": false,
  "timestamp": 1589932800000,
  "updates": [
    {
      "timestamp": 1589994672184,
      "identifier": {
        "doi": "10.1186/s13223-020-00435-z"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1186/s13223-020-00419-z"
  },
  "journal": "Allergy, Asthma & Clinical Immunology",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy"
}
